Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ISRCTN69652929) titled 'Phase I Trial: 36540 (DF-PK-01)' on Feb. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Crossover
Purpose: Device feasibility
Primary Sponsor: DF Medical Ventures Limited
Condition:
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Other
Intervention:
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The ...